Dernières nouvelles

Information non disponible

Poirier E, Desbiens C, Poirier B, Boudreau D, Jacob S, Lemieux J, Doyle C, Diorio C, Hogue JC, Provencher L

In response to: Long-term overall survival of patients diagnosed with pure tubular carcinoma of the breast might be affected by increased co-morbidities.

Article de revue

J Surg Oncol, 117 (7), 2018.

| Liens:

Poirier E, Desbiens C, Poirier B, Boudreau D, Jacob S, Lemieux J, Doyle C, Diorio C, Hogue JC, Provencher L

Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breast.

Article de revue

J Surg Oncol, 117 (6), 2018.

Résumé | Liens:

Filion M, Provencher L, Doyle C, Brisson J, Blanchette C, Duchesne T, Lemieux J

Survival Rate of Breast Cancer Patients who Participated in Clinicals Trials Versus those who did not

Article de revue

J Clin Trials, 4 , 2014.

Lemieux J, Forget G, Brochu O, Provencher L, Cantin G, Desbiens C, Doyle C, Poirier B, Camden S, Durocher M

Evaluation of eligibility and recruitment in breast cancer clinical trials.

Article de revue

Breast, 23 (4), 2014.

Résumé | Liens:

Poirier E, Desbiens C, Poirier B, Hogue JC, Lemieux J, Doyle C, Leblond AF, Cote I, Cantin G, Provencher L

Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patients.

Article de revue

Ann Pharmacother, 48 (4), 2014.

Résumé | Liens:

Cullen K, Fergus K, DasGupta T, Kong I, Fitch M, Doyle C, Adams L

Toward clinical care guidelines for supporting rehabilitative vaginal dilator use with women recovering from cervical cancer.

Article de revue

Support Care Cancer, 21 (7), 2013.

Résumé | Liens:

Provencher L, Diorio C, Hogue JC, Doyle C, Jacob S

Does breast cancer tumor size really matter that much?

Article de revue

Breast, 21 (5), 2012.

Résumé | Liens:

Filion M, Forget G, Brochu O, Provencher L, Desbiens C, Doyle C, Poirier B, DuRocher M, Camden S, Lemieux J

Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment.

Article de revue

Clin Trials, 9 (5), 2012.

Résumé | Liens:

Signaler des ajouts ou des modifications

Projets terminés récemment

  • MA-12: Étude randomisée à double insu visant à comparer le tamoxifène avec un placebo chez les patientes atteintes d'un cancer du sein étendu aux ganglions lymphatiques et qui ont complété une chimiothérapie adjuvante ..., du 1997-04-01 au 2020-03-31
Information provenant du registre des projets de recherche de l'Université Laval